Table 3.

Unadjusted and adjusted all-cause HRU in the followup period1.

VariablesUnadjusted AnalysisAdjusted Analysis
Patients with SSc, n = 2192Matched Controls, n = 2192pPatients with SSc vs Matched Controlsp
Proportion of patients with visits or admissions, n (%)OR (95% CI)
  Any IP admission688 (31.4)238 (10.9)< 0.00013.8 (3.2–4.5)< 0.0001
  Any ER visit698 (31.8)425 (19.4)< 0.00011.9 (1.7–2.2)< 0.0001
  Any OP visit22181 (99.5)1851 (84.4)< 0.0001
  Any other visits3915 (41.7)531 (24.2)< 0.00012.2 (2.0–2.6)< 0.0001
Annual no. visits or admissions, mean (SD)IRR (95% CI)
  IP admissions0.7 (2.1)0.3 (2.3)< 0.00012.4 (2.2–2.6)< 0.0001
  Total IP hospitalization days3.7 (12.7)1.1 (6.7)< 0.00013.1 (2.9–3.4)< 0.0001
  ER visits0.7 (2.5)0.3 (1.2)< 0.00012.0 (1.9–2.2)< 0.0001
  OP visits23.8 (19.4)10.3 (12.4)< 0.00012.3 (2.2–2.4)< 0.0001
  Other visits33.0 (7.6)1.0 (3.4)< 0.00012.9 (2.7–3.1)< 0.0001
  • 1 The followup period was defined as the 12-month period following the index date.

  • 2 Model could not converge because 99.5% of patients with SSc had any OP visit.

  • 3 Including laboratory tests and medical services at home. HRU: healthcare resource utilization; SSc: systemic sclerosis; IP: inpatient; ER: emergency room; OP: outpatient; IRR: incidence rate ratio.